NFκB p65 siRNA (m2) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemNFκB p65 siRNA (m2)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-44213
Quantity10 µM
Speciesmouse
NCBI Full Gene NameRELA proto-oncogene, NF-kB subunit, v-rel reticuloendotheliosis viral oncogene homolog A (avian)
NCBI Gene Aliasesp65, p65 NF-kappa B, AIF3BL3, p65 NFkB, NFKB3, CMCU
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) ANKRD49 inhibits etoposide-induced intrinsic apoptosis of GC-1 cells by modulating NF-κB signalingMolecular and cellular biochemistryJuly 1, 2019Zhou X, Wang WT, Sun J, Liu HY, Bai XY, Liu JJ, Yu BF, Guo R, Wang HL.

(2) Macrophage TCF-4 co-activates p65 to potentiate chronic inflammation and insulin resistance in miceClinical science (London, England : 1979)July 1, 2016Kang X, Hou A, Wang R, Liu D, Xiang W, Xie Q, Zhang B, Gan L, Zheng W, Miao H.

(3) T cell factor-4 functions as a co-activator to promote NF-κB-dependent MMP-15 expression in lung carcinoma cellsScientific reportsApril 5, 2016Liu Y, Xu Y, Guo S, Chen H.control). Mouse endogenous p65 was knocked down by using the two mixed commercial siRNAs (sc-29411 and sc-44213, Santa Cruz). The control siRNA was purchased from Santa Cruz (sc-37007). TCF-4 overexpression was carried

(4) The Ankyrin Repeat Domain 49 (ANKRD49) Augments Autophagy of Serum-Starved GC-1 Cells through the NF-κB PathwayPloS oneJanuary 1, 2015Wang HL, Fan SS, Pang M, Liu YH, Guo M, Liang JB, Zhang JL, Yu BF, Guo R, Xie J, et al.luciferase construct were purchased from Beyotime Institute of Biotechnology, China. Mouse NF-κB p65 siRNA (sc-44213, sc29411) and control siRNA (sc-37007) were purchased from Santa Cruz (USA). For construction of mouse

(5) Involvement of ferritin heavy chain in the preventive effect of metformin against doxorubicin-induced cardiotoxicityFree radical biology & medicineApril 1, 2013Asensio-López MC, Sánchez-Más J, Pascual-Figal DA, Abenza S, Pérez-Martínez MT, Valdés M, Lax A.

Be the First to Write a Review!